Nipah virus disease Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

10 events

Jan 2026Impact of Home Non Invasive Ventilation in Patients With Chronic Obstructive Pulmonary Disease Discharged From Assiut University Hospital

Assiut University — NA

TrialNOT YET RECRUITING

Jan 2026High-Flow Nasal Cannula Versus Noninvasive Ventilation After Extubation in Patients With COPD and Mild Hypercapnic Respiratory Failure

Assiut University — NA

TrialACTIVE NOT RECRUITING

Oct 2025Respiratory Stabilization in Chronic Acidosis Before Bronchofiberoscopy & Non-Invasive Ventilation Effectivenes

Medical University of Silesia — NA

TrialNOT YET RECRUITING

Sep 2025A New Portable Device for Non-invasive Ventilatory Support

Università Vita-Salute San Raffaele — NA

TrialRECRUITING

Sep 2025Respiratory Muscles in End-stage Lung Disease: Pathophysiological Processes & Clinical Consequences

University Medical Center Groningen

TrialNOT YET RECRUITING

Aug 2025Evaluation of the Effects on Carbon Dioxide (paCO2) of a New Oronasal Mask in Patients With Severe COPD Exacerbation Requiring Non-Invasive Mechanical Ventilation

IRCCS Azienda Ospedaliero-Universitaria di Bologna — NA

TrialNOT YET RECRUITING

Jul 2025Value of Volume Oxygenation Index to Detect Early Failure of Non-invasive Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Assiut University

TrialNOT YET RECRUITING

Mar 2025Mathematical Analysis of Signals and Clinical Parameters Provided by Non-invasive Home Ventilation Devices

Corporacion Parc Tauli

TrialRECRUITING

Mar 2025Variation in Viscoelastic Properties of Pulmonary Mucus in Patients Undergoing Mechanical Ventilation

Centre Hospitalier Intercommunal Aix-Pertuis

TrialRECRUITING

Jan 2025Assessment of Breathing Pattern During NIV

Fisher and Paykel Healthcare — NA

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Nipah virus disease.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Actemra

(tocilizumab)Orphan drugstandard

Genentech, Inc.

Interleukin-6 Receptor Antagonist [EPC]

12.1 Mechanism of Action Tocilizumab binds to both soluble and membrane-bound IL-6 receptors (sIL-6R and mIL-6R), and has been shown to inhibit IL-6-m...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Nipah virus disease.
Search all trials →

Search clinical trials for Nipah virus disease →

Recent News & Research

No recent news articles indexed yet for Nipah virus disease.
Search PubMed for Nipah virus disease →

Browse all Nipah virus disease news →

Specialist Network

Top 6 by expertise

Maxime Patout, MD

University Hospital, Rouen

Score 292 trials

Carlos Fierro, MD

Johnson County Clinical Trials

📍 MONROVIA, CA

Score 93 trials

Thomas P Monath, MD, M.D

Quigley Biopharma

📍 HARVARD, MA

Score 61 trial

Nicholas Hart, MS, ATC

GSTT

📍 RALSTON, NE

Score 41 trial4 pubs

Dariusz Wozniak

Royal Papworth Hospital NHS Foundation Trust

Score 32 trials1 pub

Thomas Monath, MD, FASTMH, M.D

Crozet BioPharma

📍 HARVARD, MA

Score 31 trial

View all Nipah virus disease specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰